A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NILM / negative for intraepithelial lesion or malignancy

[Related PubMed/MEDLINE]
Total Number of Papers: 76
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NILM  (>> Co-occurring Abbreviation)
Long Form:   negative for intraepithelial lesion or malignancy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Association between obesity and abnormal Papanicolau(Pap) smear cytology results in a resource-poor Nigerian setting. BMI, CEA, HIV, Pap, RBS, UNTH
2020 Liquid-based cytology for the detection of cervical intraepithelial lesions in Jimma town, Ethiopia. HSIL, LBC, LSIL
2019 A study of the relationship between nuclear contour thickening, nuclear enlargement and human papillomavirus infection in squamous cells. ASCUS, HPV
2019 Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014-2018. ASCs, HPV, HSILs, LSILs, TCT
2019 Evaluation of interleukin 8 and interleukin 10 cytokines in liquid based cervical cytology samples. LILM, SD
2019 Fast and Noninvasive Diagnosis of Cervical Cancer by Coherent Anti-Stokes Raman Scattering. DCNNs
2019 HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology. CIN2, CIN3, HPV, VBA
2019 Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study. CIN, CIs, HPV, ORs
2019 Prevalence of high-risk human papilloma virus in liquid-based cervical samples from Turkish women with normal and abnormal cytology. HPV, HR
10  2019 Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women. HR-HPV, pre
11  2019 [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening]. ASC-H, ASCUS, ECC, HSIL, SCC, TCT
12  2018 Anal cytology, histopathology and anoscopy in an anal dysplasia screening program: is anal cytology enough? ASCUS, HSIL, LSIL
13  2018 Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute. ASC-H, ASCUS, HR-HPV, HSIL
14  2018 HPV test result monitoring of different Bethesda categories in gynaecologic cytology: A valuable quality assurance measure. ASCUS, CPs, HPV, HSIL, LSIL, SIL
15  2018 Human papillomaviruses 16 and 58 are distributed widely among women living in Shanghai, China, with high-grade, squamous intraepithelial lesions. HPVs, HSILs, LSILs
16  2018 Lack of transformation zone in cervical Pap tests, should it be a concern? A quality assurance initiative. TZ
17  2018 Management of Atypical Squamous Cell Cases: A Prospective Study of Women seen at a Private Health Service in Northeastern Brazil. ASC-H, ASCs, ASCUS, HR-HPV, HSIL, ICCs
18  2018 Negative Pap tests in women with high-grade cervical lesions on follow-up biopsies: Contributing factors and role of human papillomavirus genotyping. HGCL, HPV, HR-HPV, Pap, PPV
19  2018 Novel cytomorphologic characteristics suggesting human papillomavirus infection in patients diagnosed as negative for intraepithelial lesion or malignancy and a comparison of diagnostic performance of three human papillomavirus tests. HPV, LBMA, Pap
20  2018 Pilot Study of an Open-source Image Analysis Software for Automated Screening of Conventional Cervical Smears. CV
21  2018 Prevalence of "unclassified" HPV genotypes among women with abnormal cytology. HPVs, RLB, SIL
22  2018 [Analysis of cervical cancer screening results in women aged 50 and older in Beijing and Guizhou]. ASC-H, ASCUS, HSIL, LSIL
23  2018 [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status]. AGC, ASC-H, ASCUS, HC2, HPV, HSIL, MALDI-TOF
24  2017 Bethesda Interobserver Reproducibility Study-2 (BIRST-2): Bethesda System 2014. ASC-H, ASCUS, BIRST, BIRST-2, HSIL, LSIL, SCC
25  2017 Cytological Features Associated with Ureaplasma Urealyticum in Pap Cervical Smear LBC
26  2017 Difference Between Cryotherapy and Follow Up Low Grade Squamous Lesion of Cervix Uteri. ---
27  2017 Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia? ASCUS, CIN3, HR-HPV
28  2017 Histopathologic and Cytologic Follow-Up in High Risk Male Patients with Unsatisfactory Anal Cytology. AIN, ASCUS, ECA, LGSIL
29  2017 Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides. HPV, Pap
30  2017 Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy. ASCUS, HPV, Pap
31  2017 Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. AGC, ASC-H, ASCCP, ASCUS, CIN, HPV, HSIL, LSIL
32  2017 Significance of Compression in Binucleation while Differentiating Reactive Cellular Changes Between Human Papillomavirus and Candida Infections HR-HPV, PCR, RCC
33  2017 [Natural changes of high-risk HPV in women with negative for intraepithelial lesion or malignancy: a prospective 1 year study]. CIN, HR-HPV, TCT
34  2016 A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology. FNRs, LBC, QC
35  2016 Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management. CIN3, HR-HPV, LBC, LSIL
36  2016 Evaluating Nuclear Membrane Irregularity for the Classification of Cervical Squamous Epithelial Cells. HSIL
37  2016 Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology. ADCY8, CDH8, HR-HPV, HSIL, LSIL, ZNF582
38  2015 A Fuzzy-C-Means-Clustering Approach: Quantifying Chromatin Pattern of Non-Neoplastic Cervical Squamous Cells. ---
39  2015 Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads. BMRT, HPV
40  2015 Distribution of human papilloma virus infections of uterine cervix among women of reproductive age--a cross sectional hospital-based study from North East India. HPV
41  2015 Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. AUC, CIN, HPV, OR, ROC
42  2015 Non-16/non-18 high-risk human papillomavirus types predominate in anal cytology categories of negative for intraepithelial lesion and atypical cells of undetermined significance. ASCUS, HR-HPV
43  2015 Significance of cytopathologist's review of Pap tests screened as negative for intraepithelial lesion or malignancy that are positive for high-risk human papillomavirus. CIN, PTs
44  2015 Squamous intraepithelial lesions in cervical tissue samples of limited adequacy and insufficient for grading as low or high grade: outcome, clinico-pathological correlates, and predictive role of p16INK4a and Ki67 biomarker staining. AIS, HSIL, LSIL, NPV, PPV, SIL
45  2015 [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I]. ASCUS, CIN, HR, LSIL
46  2014 Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid. ASCUS
47  2014 Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer. HPV, HSIL, ICC, LSIL, PCR
48  2014 NILM Pap slides from women 30 years of age and older with positive high-risk HPV DNA. Focused rescreening prior to report issuance, an enhanced quality control measure. CLIA '88, HPV, LSIL, Pap, QC
49  2014 Raman microspectroscopy for the early detection of pre-malignant changes in cervical tissue. HSIL, KMCA, PCA
50  2014 Single human papillomavirus 16 or 52 infection and later cytological findings in Japanese women with NILM or ASC-US. ASCUS, CI, HPV
51  2014 [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection]. ASCUS, HSIL
52  2013 Cervical dysplasia and pre-term birth in San Juan city hospital: a cohort retrospective study. CIN, PTL
53  2013 Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure. ASC, QC
54  2013 Frequency and patterns of abnormal Pap smears in Sudanese women with infertility: What are the perspectives? ---
55  2013 Inter-laboratory variability in the presence of human papillomavirus in normal and abnormal cervical cytology samples. ASCUS, HPV
56  2013 Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. ASCUS, HPV, HSIL, LSIL
57  2013 Using the ASC:SIL ratio, human papillomavirus, and interobserver variability to assess and monitor cytopathology fellow training performance. ASC, ASCUS, HR-HPV, IOV
58  2012 Atrophic vaginitis: concordance and interpretation of slides in the College of American Pathologists Cervicovaginal Interlaboratory Comparison Program in Gynecologic Cytopathology. ---
59  2012 Clinical performance characteristics of the Cervista HPV HR test kit in cervical cancer screening in China. ASCUS, CIN2, HPV, PCR
60  2011 Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization. CIN 1, FISH, HSIL, LSIL, SCC
61  2011 Rate of detection of high-risk HPV with two assays in women ≥ 30 years of age. CI, HC2, HPV, HR
62  2010 Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients. AIN, ASCUS, HPV, HSIL, LSIL
63  2010 Evaluation of atypical squamous cells on conventional cytology smears: An experience from a screening program practiced in limited resource settings. AGC, ASC, HPV, HSIL, LSIL, SCC
64  2010 [CD4 and CD8 T lymphocytes and NK cells in the stroma of the uterine cervix of women infected with human papillomavirus]. CIN, HPV
65  2010 [Relationship between polymorphism of hypoxia inducible factor-1alpha and cervical cancer in Han population in Sichuan Province of China]. HIF-1alpha, PCR-RFLP, SNP
66  2009 Implementation of the ThinPrep Imaging System in a tertiary military medical center. AGC, ASC, ASC, ASC-H, BAMC, HR-HPV, HSIL, LSIL, Pap, TIS
67  2008 Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study. HSIL, LSIL, SCC
68  2008 Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance. ASCUS, HR-HPV, HSIL, Pap
69  2008 Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria. ASCUS, HPV, Pap, PCR
70  2008 Internet-based gynecologic telecytology with remote automated image selection: results of a first-phase developmental trial. FOVs, SIL
71  2008 Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. CIN2, HSIL, LSIL, Pap, PCR, ROC, SIL
72  2008 Study of a manual method of liquid-based cervical cytology. MLBC
73  2007 Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions. HSIL, ICC, LBC
74  2007 [Application of high-risk human papillomavirus testing in women with abnormal cytology]. ASC, ASC-H, ASCUS, CIN 1, 2, 3, HC2, HPV, HSIL, SCC
75  2005 Altered recognition of reparative changes in ThinPrep specimens in the College of American Pathologists Gynecologic Cytology Program. ---
76  2004 The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material. ASCUS, HSIL, LSIL